Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2018 Jan 24:4:257.
doi: 10.3389/fmed.2017.00257. eCollection 2017.

Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

Argyrios Tzouvelekis  1   2 , Theodoros Karampitsakos  3 , Paschalis Ntolios  4 , Vasilios Tzilas  1 , Evangelos Bouros  1 , Evangelos Markozannes  1 , Ioanna Malliou  1 , Aris Anagnostopoulos  1 , Andreas Granitsas  1 , Paschalis Steiropoulos  2 , Katerina Dimakou  3 , Serafeim Chrysikos  4 , Nikolaos Koulouris  1 , Demosthenes Bouros  1
Affiliations
Published Erratum

Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

Argyrios Tzouvelekis et al. Front Med (Lausanne). .

Abstract

[This corrects the article on p. 213 in vol. 4, PMID: 29238708.].

Keywords: efficacy; idiopathic pulmonary fibrosis; pirfenidone; safety; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in %forced vital capacity (ΔFVC) as %predicted ± SD, at different time points following pirfenidone treatment. Time 0 denotes the onset of treatment. Deaths were treated as censored. One-way ANOVA, p < 0.05.
Figure 2
Figure 2
Changes in %diffusion capacity of lung for carbon monoxide (ΔDLCO) as %predicted ± SD, at different time points following pirfenidone treatment. Time 0 denotes the onset of treatment. Deaths were treated as censored. One-way ANOVA, p < 0.05.
See this image and copyright information in PMC

Erratum for

Publication types

LinkOut - more resources